| scholarly article | Q13442814 |
| P50 | author | Eric J. Nestler | Q5386788 |
| Johannes Thome | Q6217018 | ||
| Ronald Duman | Q7364807 | ||
| Rachael L. Neve | Q108917624 | ||
| P2093 | author name string | Eric J Nestler | |
| Jingshan Chen | |||
| Samuel S Newton | |||
| Norio Sakai | |||
| Tanya L Wallace | |||
| Lee Schlesinger | |||
| Yukihikko Shirayama | |||
| P2860 | cites work | Induction of the rat prodynorphin gene through Gs-coupled receptors may involve phosphorylation-dependent derepression and activation | Q24613067 |
| Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens | Q28350945 | ||
| Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133 | Q29617856 | ||
| Neurobiology of depression | Q29619932 | ||
| CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals | Q29620470 | ||
| Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine | Q33875193 | ||
| A molecular and cellular theory of depression | Q34064955 | ||
| A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice | Q34135412 | ||
| The cellular neurobiology of depression | Q34236134 | ||
| Molecular and cellular basis of addiction | Q34440561 | ||
| Regulation of cocaine reward by CREB. | Q34483870 | ||
| Animal behavioural studies in the evaluation of antidepressant drugs | Q35266159 | ||
| Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. | Q35778832 | ||
| A simplified method for combined immunohistochemistry and in-situ hybridization in fresh-frozen, cryocut mouse brain sections | Q38287285 | ||
| Molecular mechanisms of stress-induced proenkephalin gene regulation: CREB interacts with the proenkephalin gene in the mouse hypothalamus and is phosphorylated in response to hyperosmolar stress | Q38311572 | ||
| The validity of animal models of depression | Q40212723 | ||
| Antidepressant-type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid delta and dopamine D1 receptor stimulation | Q41115101 | ||
| CREB and memory | Q41733280 | ||
| Cognitive neuroscience and the study of memory | Q41737195 | ||
| Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum | Q41922304 | ||
| Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. | Q42556936 | ||
| The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study | Q43695146 | ||
| Noradrenergic antidepressants: does chronic treatment increase or decrease nuclear CREB-P? | Q43856059 | ||
| Altered regulation of CREB by chronic antidepressant administration in the brain of transgenic mice with impaired glucocorticoid receptor function | Q43942965 | ||
| cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs. | Q43954518 | ||
| Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein. | Q43972766 | ||
| Inducible and brain region-specific CREB transgenic mice | Q44000806 | ||
| Strain-specific effects of antidepressants on escape deficits induced by inescapable shock | Q44247612 | ||
| Modulation of morphine-induced sensitization by endogenous kappa opioid systems in the rat. | Q44340169 | ||
| Dopamine receptor mRNA expression patterns by opioid peptide cells in the nucleus accumbens of the rat: a double in situ hybridization study | Q44341091 | ||
| Involvement of delta-opioid receptors in the effects induced by endogenous enkephalins on learned helplessness model | Q44349824 | ||
| Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study | Q45078410 | ||
| Increased temporal cortex CREB concentrations and antidepressant treatment in major depression | Q48331913 | ||
| Transgenic animals with inducible, targeted gene expression in brain | Q48398754 | ||
| Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. | Q48635095 | ||
| Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect | Q48894385 | ||
| cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. | Q51401037 | ||
| Gender differences in learned helplessness behavior are influenced by genetic background. | Q52165519 | ||
| Learned helplessness in the rat | Q52313651 | ||
| Neuronal plasticity and survival in mood disorders. | Q52541461 | ||
| Pharmacological actions of the antidepressant venlafaxine beyond aminergic receptors | Q73701103 | ||
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dynorphin | Q324076 |
| nucleus accumbens | Q1476178 | ||
| P304 | page(s) | 10883-10890 | |
| P577 | publication date | 2002-12-01 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect | |
| P478 | volume | 22 |
| Q104509588 | A projection from the paraventricular nucleus of the thalamus to the shell of the nucleus accumbens contributes to footshock stress-induced social avoidance |
| Q34463599 | A proposed hypothalamic-thalamic-striatal axis for the integration of energy balance, arousal, and food reward |
| Q36281799 | Alcohol-induced plasticity in the dynorphin/kappa-opioid receptor system |
| Q30372214 | Alterations in leukocyte transcriptional control pathway activity associated with major depressive disorder and antidepressant treatment. |
| Q47555397 | Alterations in mGlu5 receptor expression and function in the striatum in a rat depression model. |
| Q45074557 | Altered phosphorylation, electrophysiology, and behavior on attenuation of PDE4B action in hippocampus |
| Q95801666 | Altered sensitivity to rewarding and aversive drugs in mice with inducible disruption of cAMP response element-binding protein function within the nucleus accumbens |
| Q34421107 | An Improved Antagonist Radiotracer for the κ-Opioid Receptor: Synthesis and Characterization of (11)C-LY2459989. |
| Q34513500 | An mGluR2/3 antagonist, MGS0039, exerts antidepressant and anxiolytic effects in behavioral models in rats |
| Q24653466 | Anabolic-androgenic steroid dependence: an emerging disorder |
| Q35592881 | Analysis of target genes regulated by chronic electroconvulsive therapy reveals role for Fzd6 in depression |
| Q38931373 | Antidepressant Action on Mitochondrial Dysfunction in Psychiatric Disorders. |
| Q37346336 | Antidepressant- and anxiolytic-like effects of the phosphodiesterase-4 inhibitor rolipram on behavior depend on cyclic AMP response element binding protein-mediated neurogenesis in the hippocampus |
| Q33621097 | Antidepressant-like effects of kappa-opioid receptor antagonists in Wistar Kyoto rats |
| Q37206280 | Assessing the neuronal serotonergic target-based antidepressant stratagem: impact of in vivo interaction studies and knockout models |
| Q44347124 | Association of in vivo κ-opioid receptor availability and the transdiagnostic dimensional expression of trauma-related psychopathology |
| Q37512931 | Association of the PDYN gene with alcohol dependence and the propensity to drink in negative emotional states |
| Q90713978 | Behavioral Pharmacology of Novel Kappa Opioid Receptor Antagonists in Rats |
| Q37082551 | Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis. |
| Q35375156 | Blockade of kappa opioid receptors attenuates the development of depressive-like behaviors induced by cocaine withdrawal in rats |
| Q28263751 | Blunted Ventral Striatum Development in Adolescence Reflects Emotional Neglect and Predicts Depressive Symptoms |
| Q35620931 | CREB Regulates Experience-Dependent Spine Formation and Enlargement in Mouse Barrel Cortex |
| Q36952744 | CREB binding and activity in brain: regional specificity and induction by electroconvulsive seizure |
| Q52299778 | CREB involvement in the regulation of striatal prodynorphin by nicotine. |
| Q42435885 | CREB is necessary for synaptic maintenance and learning-induced changes of the AMPA receptor GluA1 subunit |
| Q37291610 | CREB regulation of nucleus accumbens excitability mediates social isolation-induced behavioral deficits |
| Q36718053 | Candidate genes for antidepressant response to selective serotonin reuptake inhibitors |
| Q36076541 | Central kappa-opioid receptor-mediated antidepressant-like effects of nor-Binaltorphimine: behavioral and BDNF mRNA expression studies |
| Q46825379 | Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates. |
| Q47297525 | Circuit-based frameworks of depressive behaviors: The role of reward circuitry and beyond |
| Q33812862 | Cognitive dysfunction in major depression and Alzheimer's disease is associated with hippocampal-prefrontal cortex dysconnectivity |
| Q30446679 | Corticotropin-releasing factor (CRF)-induced disruption of attention in rats is blocked by the κ-opioid receptor antagonist JDTic |
| Q36605795 | Cyclic AMP response element binding protein and brain-derived neurotrophic factor: molecules that modulate our mood? |
| Q37199127 | Desipramine reduces stress-activated dynorphin expression and CREB phosphorylation in NAc tissue |
| Q36728154 | Development of κ opioid receptor antagonists |
| Q40625686 | Differential effects of 9-cis, 13-cis and all-trans retinoic acids on the neuronal differentiation of human neuroblastoma cells |
| Q28273954 | Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats |
| Q30848010 | Disinhibition of somatostatin-positive GABAergic interneurons results in an anxiolytic and antidepressant-like brain state |
| Q38276410 | Does the kappa opioid receptor system contribute to pain aversion? |
| Q26997989 | Drug withdrawal conceptualized as a stressor. |
| Q36942175 | Dynorphin and the pathophysiology of drug addiction |
| Q24650168 | Dynorphin, stress, and depression |
| Q36101215 | Effects of acute and chronic social defeat stress are differentially mediated by the dynorphin/kappa-opioid receptor system |
| Q34293684 | Effects of estrogen treatment on expression of brain-derived neurotrophic factor and cAMP response element-binding protein expression and phosphorylation in rat amygdaloid and hippocampal structures |
| Q44344204 | Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats |
| Q39015823 | Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression |
| Q35581558 | Endogenous opiates and behavior: 2002 |
| Q44625519 | Estrogen mediates sex differences in stress-induced prefrontal cortex dysfunction |
| Q34073200 | Evaluation of the agonist PET radioligand [¹¹C]GR103545 to image kappa opioid receptor in humans: kinetic model selection, test-retest reproducibility and receptor occupancy by the antagonist PF-04455242. |
| Q37388539 | Fetal alcohol spectrum disorder-associated depression: evidence for reductions in the levels of brain-derived neurotrophic factor in a mouse model |
| Q37479393 | Fluoxetine exposure during adolescence alters responses to aversive stimuli in adulthood |
| Q35709598 | From monoamines to genomic targets: a paradigm shift for drug discovery in depression |
| Q26996546 | Gender differences in genetic mouse models evaluated for depressive-like and antidepressant behavior |
| Q39268697 | Gene expression profiling in the hippocampus of learned helpless and nonhelpless rats |
| Q37938886 | Genetic approaches to investigate the role of CREB in neuronal plasticity and memory. |
| Q47901504 | Histone Lysine Demethylases of JMJD2 or KDM4 Family are Important Epigenetic Regulators in Reward Circuitry in the Etiopathology of Depression |
| Q37281367 | Imipramine treatment and resiliency exhibit similar chromatin regulation in the mouse nucleus accumbens in depression models |
| Q35182618 | In vivo and in vitro characterization of naltrindole-derived ligands at the κ-opioid receptor |
| Q43546120 | Induction of activating transcription factors (ATFs) ATF2, ATF3, and ATF4 in the nucleus accumbens and their regulation of emotional behavior. |
| Q48450844 | Induction of inducible cAMP early repressor expression in nucleus accumbens by stress or amphetamine increases behavioral responses to emotional stimuli. |
| Q42052569 | Involvement of dynorphin and kappa opioid receptor in yohimbine-induced reinstatement of heroin seeking in rats |
| Q24647830 | Kappa opioid antagonists: past successes and future prospects |
| Q57166284 | Kappa opioid receptor binding in major depression: A pilot study |
| Q35147542 | Kappa opioid receptor signaling in the basolateral amygdala regulates conditioned fear and anxiety in rats |
| Q41639865 | Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials |
| Q24657982 | Kappa-opioid ligands in the study and treatment of mood disorders |
| Q90127391 | Linkage of Non-receptor Tyrosine Kinase Fyn to mGlu5 Receptors in Striatal Neurons in a Depression Model |
| Q37362473 | Long-term antagonism of κ opioid receptors prevents escalation of and increased motivation for heroin intake |
| Q34527874 | Major Depressive Disorder and Kappa Opioid Receptor Antagonists |
| Q38397184 | Meta-analysis demonstrates lack of association of the GSK3B -50C/T polymorphism with risk of bipolar disorder |
| Q44693587 | Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood |
| Q43169264 | Microenvironmental regulation of the progression of oral potentially malignant disorders towards malignancy |
| Q30476986 | Molecular and genetic substrates linking stress and addiction |
| Q44920124 | Nestin promoter/enhancer directs transgene expression to precursors of adult generated periglomerular neurons |
| Q35236802 | Neural plasticity: consequences of stress and actions of antidepressant treatment |
| Q24656267 | Neurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodents |
| Q36922912 | Neuroplasticity mediated by altered gene expression |
| Q28111990 | Nicotine and endogenous opioids: Neurochemical and pharmacological evidence |
| Q43266640 | Nicotine withdrawal and kappa-opioid receptors. |
| Q36675341 | Opioid receptors: distinct roles in mood disorders |
| Q48120994 | Orexins in the paraventricular nucleus of the thalamus mediate anxiety-like responses in rats. |
| Q35588162 | Overexpression of CREB in the nucleus accumbens shell increases cocaine reinforcement in self-administering rats |
| Q30497021 | Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models |
| Q24658266 | Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence |
| Q38197608 | Psychiatric neural networks and neuropharmacology: Selected advances and novel implications |
| Q36781079 | RNA interference-mediated phosphodiesterase 4D splice variants knock-down in the prefrontal cortex produces antidepressant-like and cognition-enhancing effects. |
| Q42092713 | Recapitulation and reversal of a persistent depression-like syndrome in rodents |
| Q34507757 | Reflections on: "A general role for adaptations in G-Proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function". |
| Q35913886 | Regulation of antidepressant activity by cAMP response element binding proteins |
| Q33852098 | Regulation of anxiety and initiation of sexual behavior by CREB in the nucleus accumbens |
| Q24300047 | Regulation of brain-derived neurotrophic factor exon IV transcription through calcium responsive elements in cortical neurons |
| Q34270890 | Regulation of gene expression and cocaine reward by CREB and ΔFosB |
| Q36565615 | Relative Timing Between Kappa Opioid Receptor Activation and Cocaine Determines the Impact on Reward and Dopamine Release |
| Q28261223 | Repeated quinpirole treatment increases cAMP-dependent protein kinase activity and CREB phosphorylation in nucleus accumbens and reverses quinpirole-induced sensorimotor gating deficits in rats |
| Q33611438 | Reward Network Immediate Early Gene Expression in Mood Disorders |
| Q26991739 | Role of kappa-opioid receptors in stress and anxiety-related behavior |
| Q26782608 | Role of the Brain's Reward Circuitry in Depression: Transcriptional Mechanisms |
| Q36554599 | Roles of nucleus accumbens CREB and dynorphin in dysregulation of motivation |
| Q35626923 | SKF83959 produces antidepressant effects in a chronic social defeat stress model of depression through BDNF-TrkB pathway |
| Q37349384 | Salvinorin A and derivatives: protection from metabolism does not prolong short-term, whole-brain residence |
| Q57191796 | Selective Depletion of CREB in Serotonergic Neurons Affects the Upregulation of Brain-Derived Neurotrophic Factor Evoked by Chronic Fluoxetine Treatment |
| Q34296460 | Serum response factor promotes resilience to chronic social stress through the induction of DeltaFosB. |
| Q26770785 | Sex Differences in Kappa Opioid Receptor Function and Their Potential Impact on Addiction |
| Q89267164 | Sex differences in neural mechanisms mediating reward and addiction |
| Q24685275 | Social defeat stress-induced behavioral responses are mediated by the endogenous kappa opioid system |
| Q35418086 | Social defeat stress-induced sensitization and escalated cocaine self-administration: the role of ERK signaling in the rat ventral tegmental area |
| Q34686632 | Stress, depression, and neuroplasticity: a convergence of mechanisms |
| Q30540915 | Stress-induced anhedonia is associated with hypertrophy of medium spiny neurons of the nucleus accumbens. |
| Q24655307 | Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria |
| Q37187299 | Suppression of the MEK/ERK signaling pathway reverses depression-like behaviors of CRF2-deficient mice |
| Q37349893 | TLR4 signaling in VTA dopaminergic neurons regulates impulsivity through tyrosine hydroxylase modulation |
| Q97884820 | Targeting opioid receptor signaling in depression: do we need selective κ opioid receptor antagonists? |
| Q34553463 | The Behavioral Effects of the Antidepressant Tianeptine Require the Mu-Opioid Receptor. |
| Q47639681 | The Dopamine Receptor D3 Regulates Lipopolysaccharide-Induced Depressive-Like Behavior in Mice |
| Q90363031 | The circadian gene Nr1d1 in the mouse nucleus accumbens modulates sociability and anxiety-related behaviour |
| Q46727182 | The decreased cyclic-AMP dependent-protein kinase A function in the nucleus accumbens: a role in alcohol drinking but not in anxiety-like behaviors in rats |
| Q37589122 | The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors |
| Q37946259 | The dynorphin/κ-opioid receptor system and its role in psychiatric disorders |
| Q30484058 | The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitement |
| Q88959360 | The impact of sex as a biological variable in the search for novel antidepressants |
| Q34650892 | The kappa opioid receptor: from addiction to depression, and back. |
| Q37483673 | The kappa-opiate receptor impacts the pathophysiology and behavior of substance use. |
| Q36992810 | The kappa-opioid agonist U69,593 blocks cocaine-induced enhancement of brain stimulation reward |
| Q36248049 | The role of cAMP response element-binding proteins in mediating stress-induced vulnerability to drug abuse |
| Q33890721 | The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse |
| Q42605903 | The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. |
| Q90478372 | Trace Amine-Associated Receptor 5 Provides Olfactory Input Into Limbic Brain Areas and Modulates Emotional Behaviors and Serotonin Transmission |
| Q42677754 | Transgenic mice lacking CREB and CREM in noradrenergic and serotonergic neurons respond differently to common antidepressants on tail suspension test. |
| Q37687946 | Utility of genetically modified mice for understanding the neurobiology of substance use disorders |
| Q33591477 | Virus-mediated shRNA knockdown of prodynorphin in the rat nucleus accumbens attenuates depression-like behavior and cocaine locomotor sensitization |
| Q60106514 | Voluntary wheel running promotes resilience to chronic social defeat stress in mice: a role for nucleus accumbens ΔFosB |
| Q80415280 | [Synaptic vesicle proteins and psychiatric disorders] |
| Q30470838 | cAMP response element binding protein phosphorylation in nucleus accumbens underlies sustained recovery of sensorimotor gating following repeated D₂-like receptor agonist treatment in rats |
| Q48103045 | cAMP response element-binding protein deficiency allows for increased neurogenesis and a rapid onset of antidepressant response. |
| Q37455456 | kappa-Opioid receptor signaling and brain reward function |
| Q37102862 | p38: the link between the kappa-opioid receptor and dysphoria. |
| Q35592974 | ΔFosB enhances the rewarding effects of cocaine while reducing the pro-depressive effects of the kappa-opioid receptor agonist U50488. |
Search more.